SCHEMBL7304085

SCHEMBL7304085

CCC(C)C(NC(=O)OCc1ccc2ccccc2n1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 2/20 0.48
CTSB P07858 2/20 0.48
CTSS P25774 2/20 0.48
ADAMTS4 O75173 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
TYR P14679 1/20 0.47
LMNA P02545 1/20 0.47
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
CTSK P43235 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
RAB9A P51151 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYSLTR1 Q9Y271 4/20 0.45
GPBAR1 Q8TDU6 2/20 0.45
MME P08473 1/20 0.45
ECE1 P42892 1/20 0.45
ELANE P08246 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7299398 1.00 CTSL (0.48) CTSLCTSBCTSSADAMTS4MEN1
SCHEMBL7307096 0.90 ADAMTS4 (0.55) ADAMTS4CYP1A2CYSLTR1GPBAR1CYSLTR2
SCHEMBL7298298 0.90 ADAMTS4 (0.55) ADAMTS4CYP1A2CYSLTR1GPBAR1CYSLTR2
SCHEMBL7295767 0.85 GPBAR1 (0.46) ADAMTS4CTSKCYP1A2CYSLTR1GPBAR1
SCHEMBL7306884 0.82 CYP1A2 (0.48) ADAMTS4CYP1A2CYSLTR1GPBAR1CYSLTR2
SCHEMBL7306877 0.82 CYP1A2 (0.48) ADAMTS4CYP1A2CYSLTR1GPBAR1CYSLTR2
SCHEMBL7304710 0.81 CTSL (0.47) CTSLCTSBCTSSMEN1KMT2A
SCHEMBL7310554 0.80 RAB9A (0.55) CTSLCTSBCTSSADAMTS4MEN1
SCHEMBL7310548 0.80 RAB9A (0.55) CTSLCTSBCTSSADAMTS4MEN1
SCHEMBL8984331 0.79 ALOX5AP (0.46) ADAMTS4CYP1A2CYSLTR1GPBAR1CYSLTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0652009-A1 Identification and use of protease inhibitors ELI LILLY AND COMPANY (US) 1995-05-10 EP disclosed
CN-1082035-A The inhibitors of hiv protease that is used for the treatment of AIDS LILLY CO ELI (US) 1994-02-16 CN disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed